Search Results - "Chendamarai, Ezhil"

Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells by Karpova, Darja, Ritchey, Julie K., Holt, Matthew S., Abou-Ezzi, Grazia, Monlish, Darlene, Batoon, Lena, Millard, Susan, Spohn, Gabriele, Wiercinska, Eliza, Chendamarai, Ezhil, Yang, Wei, Christ, Stephanie, Gehrs, Leah, Schuettpelz, Laura G., Dembowsky, Klaus, Pettit, Allison R., Rettig, Michael P., Bonig, Halvard, DiPersio, John F.

“…Interaction between the chemokine receptor CXCR4 and its chief ligand CXCL12 plays a critical role in the retention and migration of hematopoietic stem and…”
Get full text

AML-080 Modeling Flotetuzumab-Associated Cytokine Release Syndrome (CRS) in AML Using In Vitro and In Vivo Preclinical Models by Patel, Dilan, Chendamarai, Ezhil, Ritchey, Julie, Rettig, Michael, Gehrs, Leah, Moore, Paul, Alderson, Ralph, Bonvini, Ezio, Christopher, Matthew, DiPersio, John

“…Flotetuzumab (FLZ) is a dual affinity retargeting agent (DART) that is being investigated for the treatment of relapsed and refractory acute myeloid leukemia…”
Get full text

POSTER: AML-080 Modeling Flotetuzumab-Associated Cytokine Release Syndrome (CRS) in AML Using In Vitro and In Vivo Preclinical Models by Patel, Dilan, Chendamarai, Ezhil, Ritchey, Julie, Rettig, Michael, Gehrs, Leah, Moore, Paul, Alderson, Ralph, Bonvini, Ezio, Christopher, Matthew, DiPersio, John

Get full text

Comparison of Clinical Outcomes of Patients with Relapsed Acute Promyelocytic Leukemia Induced with Arsenic Trioxide and Consolidated with Either an Autologous Stem Cell Transplant or an Arsenic Trioxide–Based Regimen by Thirugnanam, Rajasekar, George, Biju, Chendamarai, Ezhil, Lakshmi, Kavitha M, Balasubramanian, Poonkuzhali, Viswabandya, Auro, Srivastava, Alok, Chandy, Mammen, Mathews, Vikram

“…In patients with relapsed acute promyelocytic leukemia (APL), the best consolidation regimen following induction of remission with arsenic trioxide (ATO)…”
Get full text